These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3811723)
1. [Features of the clinical picture, course and treatment of myasthenia in late middle-aged and aged persons]. Gladyshev SS; Gekht BM; Kolomenskaia EA Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1633-8. PubMed ID: 3811723 [TBL] [Abstract][Full Text] [Related]
2. [Variants of the pathogenetic therapy of myasthenia gravis]. Lobzin VS; Poliakova LA; Fedotova TA Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1609-14. PubMed ID: 3434054 [TBL] [Abstract][Full Text] [Related]
3. [Use of therapeutic plasmapheresis in patients with generalized myasthenia during exacerbations in the late period following thymectomy]. Marchuk AI; Golovteev VV; Sapin SM; Shagal DI Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):330-3. PubMed ID: 3705836 [TBL] [Abstract][Full Text] [Related]
4. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases. McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588 [TBL] [Abstract][Full Text] [Related]
5. Clinical spectrum of myasthenia gravis and problems of management. Dhamija RM; Venkataraman S; Roy AK; Sanchetee PC; Bhargava AK J Assoc Physicians India; 1991 Feb; 39(2):181. PubMed ID: 1885481 [TBL] [Abstract][Full Text] [Related]
6. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis. Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178 [TBL] [Abstract][Full Text] [Related]
7. [Corticosteroid therapy combined with thymectomy in myasthenia gravis]. Ito N; Hirayama K; Baba M; Yamaguchi Y; Kuroda N Rinsho Shinkeigaku; 1983 Apr; 23(4):338-46. PubMed ID: 6883880 [No Abstract] [Full Text] [Related]
14. Myasthenia gravis: effect of immunoactive therapies. Fornádi L; Horváth R; Bárdosi Z; Szobor A Acta Med Hung; 1994; 50(1-2):83-92. PubMed ID: 7638045 [TBL] [Abstract][Full Text] [Related]
15. [Significance of thymectomy for the treatment of myasthenia gravis pseudoparalytica]. Becker H; Ungeheuer E Med Klin; 1973 Jun; 68(22):731-5. PubMed ID: 4715781 [No Abstract] [Full Text] [Related]
16. [Myasthenia gravis. Longitudinal course and therapeutic aspects]. Klingler D; Necek S; Brücke P Wien Med Wochenschr; 1978 Jun; 128(12):348-52. PubMed ID: 664725 [No Abstract] [Full Text] [Related]
18. [Splenectomy in the treatment of severe generalized myasthenia gravis (first experience)]. Kuzin MI; Shkrob OS; Gekht BM; Vetshev PS; Shagal DI; Zaĭrat'iants OV; Khodzhaev ZSh; Ippolitov IKh Khirurgiia (Mosk); 1990 Aug; (8):95-9. PubMed ID: 2259184 [TBL] [Abstract][Full Text] [Related]
19. Favorable results of thymectomy combined with prednisolone alternate-day administration in myasthenia gravis. Yamaguchi Y; Saito Y; Baba M; Obata S Jpn J Surg; 1987 Jan; 17(1):14-20. PubMed ID: 3573441 [TBL] [Abstract][Full Text] [Related]
20. [Features of the clinical picture and results of the treatment of myasthenia in Uzbekistan]. Samibaev MKh; Gabrielian MI; Allaz-ogly N Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1658-61. PubMed ID: 2934919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]